4//SEC Filing
Rosen Howard B 4
Accession 0001209191-23-058477
CIK 0001427925other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:21 PM ET
Size
7.7 KB
Accession
0001209191-23-058477
Insider Transaction Report
Form 4
Rosen Howard B
Director
Transactions
- Award
Common Stock
2023-10-10+581→ 5,293 total - Award
Stock Option (Right to Buy)
2023-10-10+3,487→ 3,487 totalExercise: $0.68From: 2024-10-10Exp: 2033-10-10→ Common Stock (3,487 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
- [F3]Effective on October 25, 2022, the issuer effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F4]100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001307068
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:21 PM ET
- Size
- 7.7 KB